Trial · NCT03703310
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of New BCCs Per Participant | Patidegib Topical Gel, 2%, | 2.84 | Standard Deviation 3.39 | New basal cell carcinomas | |
| Number of New BCCs Per Participant | Patidegib Topical Gel, Vehicle | 4.03 | Standard Deviation 4.76 | New basal cell carcinomas | |
| Number of New Surgically Eligible BCCs (nSEBs) Per Participant | Patidegib Topical Gel, 2%, | 0.71 | Standard Deviation 1.28 | New basal cell carcinomas | |
| Number of New Surgically Eligible BCCs (nSEBs) Per Participant | Patidegib Topical Gel, Vehicle | 0.91 | Standard Deviation 1.61 | New basal cell carcinomas | |
| Percentage of Participants Developing >=2 Facial New BCCs | Patidegib Topical Gel, 2%, | 45 | Participants | ||
| Percentage of Participants Developing >=2 Facial New BCCs | Patidegib Topical Gel, Vehicle | 55 | Participants | ||
| Percentage of Participants Developing >=1 Facial New BCCs | Patidegib Topical Gel, 2%, | 56 | Participants | ||
| Percentage of Participants Developing >=1 Facial New BCCs | Patidegib Topical Gel, Vehicle | 65 | Participants | ||
| Number of New BCCs Per Participant | Patidegib Topical Gel, 2%, | 2.46 | Standard Deviation 3.42 | New basal cell carcinomas | |
| Number of New BCCs Per Participant | Patidegib Topical Gel, Vehicle | 3.15 | Standard Deviation 3.94 | New basal cell carcinomas | |
| Number of New BCCs Per Participant | Patidegib Topical Gel, 2%, | 1.68 | Standard Deviation 2.82 | New basal cell carcinomas | |
| Number of New BCCs Per Participant | Patidegib Topical Gel, Vehicle | 2.12 | Standard Deviation 2.96 | New basal cell carcinomas | |
| Change in Advanced Basal Cell Carcinoma Index (aBCCdex) Lesion Symptom Score Scale Score | Patidegib Topical Gel, 2%, | 11.49 | Standard Deviation 18.365 | score on a scale | |
| Change in Advanced Basal Cell Carcinoma Index (aBCCdex) Lesion Symptom Score Scale Score | Patidegib Topical Gel, Vehicle | 15.54 | Standard Deviation 21.002 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03703310/results